WIDEPOINT CORP — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that WIDEPOINT CORP filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $150.55M | Mar 25, 2026 |
| FY2025 | Dec 31, 2024 | $142.57M | Mar 25, 2026 |
| FY2024 | Dec 31, 2023 | $106.03M | Apr 15, 2025 |
| FY2023 | Dec 31, 2022 | $94.10M | Mar 26, 2024 |
| FY2022 | Dec 31, 2021 | $87.34M | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $180.34M | Mar 28, 2022 |
| FY2020 | Dec 31, 2019 | $101.72M | Mar 23, 2021 |
| FY2019 | Dec 31, 2018 | $83.68M | Mar 24, 2020 |
| FY2018 | Dec 31, 2017 | $75.88M | Mar 22, 2019 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | $75.88M | Mar 21, 2018 |
| FY2017 | Dec 31, 2016 | $78.42M | Mar 21, 2018 |
| FY2015 | Dec 31, 2015 | $18.71M | Mar 15, 2016 |
| FY2015 | Sep 30, 2015 | $16.99M | Mar 15, 2016 |
| FY2015 | Jun 30, 2015 | $17.43M | Mar 15, 2016 |
| FY2015 | Mar 31, 2015 | $17.70M | Mar 15, 2016 |
| FY2015 | Dec 31, 2014 | $16.76M | Mar 15, 2016 |
| FY2015 | Sep 30, 2014 | $14.56M | Mar 15, 2016 |
| FY2015 | Jun 30, 2014 | $12.39M | Mar 15, 2016 |
| FY2015 | Mar 31, 2014 | $9.60M | Mar 15, 2016 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $21.01M | Mar 25, 2026 |
| FY2025 | Dec 31, 2024 | $19.00M | Mar 25, 2026 |
| FY2024 | Dec 31, 2023 | $15.65M | Apr 15, 2025 |
| FY2023 | Dec 31, 2022 | $14.58M | Mar 26, 2024 |
| FY2022 | Dec 31, 2021 | $16.37M | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $20.46M | Mar 28, 2022 |
| FY2020 | Dec 31, 2019 | $17.38M | Mar 23, 2021 |
| FY2019 | Dec 31, 2018 | $15.27M | Mar 24, 2020 |
| FY2018 | Dec 31, 2017 | $13.69M | Mar 22, 2019 |
| FY2017 | Dec 31, 2016 | $14.01M | Mar 21, 2018 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($2.75M) | Mar 25, 2026 |
| FY2025 | Dec 31, 2024 | ($1.93M) | Mar 25, 2026 |
| FY2024 | Dec 31, 2023 | ($4.05M) | Apr 15, 2025 |
| FY2023 | Dec 31, 2022 | ($23.59M) | Mar 26, 2024 |
| FY2022 | Dec 31, 2021 | $341.1K | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $10.32M | Mar 28, 2022 |
| FY2020 | Dec 31, 2019 | $226.3K | Mar 23, 2021 |
| FY2019 | Dec 31, 2018 | ($1.46M) | Mar 24, 2020 |
| FY2018 | Dec 31, 2017 | ($3.53M) | Mar 22, 2019 |
| FY2017 | Dec 31, 2016 | ($4.13M) | Mar 21, 2018 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($2.78M) | Mar 25, 2026 |
| FY2025 | Dec 31, 2024 | ($1.88M) | Mar 25, 2026 |
| FY2024 | Dec 31, 2023 | ($3.70M) | Apr 15, 2025 |
| FY2023 | Dec 31, 2022 | ($19.63M) | Mar 26, 2024 |
| FY2022 | Dec 31, 2021 | $607.6K | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $3.22M | Mar 28, 2022 |
| FY2020 | Dec 31, 2019 | $885.3K | Mar 23, 2021 |
| FY2019 | Dec 31, 2018 | ($190.4K) | Mar 24, 2020 |
| FY2018 | Dec 31, 2017 | ($3.46M) | Mar 22, 2019 |
| FY2017 | Dec 31, 2016 | ($4.16M) | Mar 21, 2018 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2018 | Dec 31, 2018 | $0 | Mar 22, 2019 |
| FY2018 | Dec 31, 2017 | $219.1K | Mar 22, 2019 |
| FY2017 | Dec 31, 2016 | $699.0K | Mar 21, 2018 |
| FY2016 | Dec 31, 2015 | $673.1K | Mar 30, 2017 |
| FY2015 | Dec 31, 2014 | $480.1K | Mar 15, 2016 |
| FY2015 | Dec 31, 2013 | $73.6K | Mar 15, 2016 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $5.71M | Mar 25, 2026 |
| FY2025 | Dec 31, 2024 | $1.68M | Mar 25, 2026 |
| FY2024 | Dec 31, 2023 | $625.2K | Apr 15, 2025 |
| FY2023 | Dec 31, 2022 | $6.07M | Mar 26, 2024 |
| FY2022 | Dec 31, 2021 | ($1.22M) | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $6.39M | Mar 28, 2022 |
| FY2020 | Dec 31, 2019 | $5.85M | Mar 23, 2021 |
| FY2019 | Dec 31, 2018 | ($2.13M) | Mar 24, 2020 |
| FY2018 | Dec 31, 2017 | ($2.99M) | Mar 22, 2019 |
| FY2017 | Dec 31, 2016 | $2.71M | Mar 21, 2018 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $237.4K | Mar 25, 2026 |
| FY2025 | Dec 31, 2024 | $117.9K | Mar 25, 2026 |
| FY2024 | Dec 31, 2023 | $208.2K | Apr 15, 2025 |
| FY2023 | Dec 31, 2022 | $245.0K | Mar 26, 2024 |
| FY2022 | Dec 31, 2021 | $258.2K | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $254.4K | Mar 28, 2022 |
| FY2020 | Dec 31, 2019 | $370.3K | Mar 23, 2021 |
| FY2019 | Dec 31, 2018 | $261.5K | Mar 24, 2020 |
| FY2018 | Dec 31, 2017 | $695.6K | Mar 22, 2019 |
| FY2017 | Dec 31, 2016 | $274.7K | Mar 21, 2018 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $79.81M | Mar 25, 2026 |
| FY2025 | Dec 31, 2024 | $71.58M | Mar 25, 2026 |
| FY2024 | Dec 31, 2023 | $51.30M | Apr 15, 2025 |
| FY2023 | Dec 31, 2022 | $49.01M | Mar 26, 2024 |
| FY2022 | Dec 31, 2021 | $75.49M | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $101.32M | Mar 28, 2022 |
| FY2020 | Dec 31, 2019 | $64.29M | Mar 23, 2021 |
| FY2019 | Dec 31, 2018 | $47.06M | Mar 24, 2020 |
| FY2018 | Dec 31, 2017 | $45.89M | Mar 22, 2019 |
| FY2017 | Dec 31, 2016 | $47.18M | Mar 21, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $68.28M | Mar 25, 2026 |
| FY2025 | Dec 31, 2024 | $58.00M | Mar 25, 2026 |
| FY2024 | Dec 31, 2023 | $36.62M | Apr 15, 2025 |
| FY2023 | Dec 31, 2022 | $31.26M | Mar 26, 2024 |
| FY2022 | Dec 31, 2021 | $33.81M | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $60.77M | Mar 28, 2022 |
| FY2020 | Dec 31, 2019 | $39.35M | Mar 23, 2021 |
| FY2019 | Dec 31, 2018 | $22.64M | Mar 24, 2020 |
| FY2018 | Dec 31, 2017 | $20.68M | Mar 22, 2019 |
| FY2017 | Dec 31, 2016 | $18.90M | Mar 21, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $11.53M | Mar 25, 2026 |
| FY2025 | Dec 31, 2024 | $13.58M | Mar 25, 2026 |
| FY2025 | Dec 31, 2023 | $14.68M | Mar 25, 2026 |
| FY2024 | Dec 31, 2022 | $17.75M | Apr 15, 2025 |
| FY2023 | Dec 31, 2021 | $41.68M | Mar 26, 2024 |
| FY2022 | Dec 31, 2020 | $40.55M | Mar 31, 2023 |
| FY2021 | Dec 31, 2019 | $24.94M | Mar 28, 2022 |
| FY2020 | Dec 31, 2018 | $24.42M | Mar 23, 2021 |
| FY2019 | Dec 31, 2017 | $25.21M | Mar 24, 2020 |
| FY2018 | Dec 31, 2016 | $28.28M | Mar 22, 2019 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $5.81M | Mar 25, 2026 |
| FY2025 | Dec 31, 2024 | $5.81M | Mar 25, 2026 |
| FY2024 | Dec 31, 2023 | $5.81M | Apr 15, 2025 |
| FY2023 | Dec 31, 2022 | $5.81M | Mar 26, 2024 |
| FY2023 | Dec 31, 2021 | $22.09M | Mar 26, 2024 |
| FY2023 | Dec 31, 2020 | $18.56M | Mar 26, 2024 |
| FY2021 | Dec 31, 2019 | $18.56M | Mar 28, 2022 |
| FY2019 | Dec 31, 2018 | $18.56M | Mar 24, 2020 |
| FY2018 | Dec 31, 2017 | $18.56M | Mar 22, 2019 |
| FY2017 | Dec 31, 2016 | $18.56M | Mar 21, 2018 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($91.83M) | Mar 25, 2026 |
| FY2025 | Dec 31, 2024 | ($89.08M) | Mar 25, 2026 |
| FY2024 | Dec 31, 2023 | ($87.15M) | Apr 15, 2025 |
| FY2023 | Dec 31, 2022 | ($83.10M) | Mar 26, 2024 |
| FY2022 | Dec 31, 2021 | ($59.52M) | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | ($59.86M) | Mar 28, 2022 |
| FY2020 | Dec 31, 2019 | ($70.18M) | Mar 23, 2021 |
| FY2019 | Dec 31, 2018 | ($70.41M) | Mar 24, 2020 |
| FY2018 | Dec 31, 2017 | ($68.95M) | Mar 22, 2019 |
| FY2017 | Dec 31, 2016 | ($65.42M) | Mar 21, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $9.82M | Mar 25, 2026 |
| FY2025 | Dec 31, 2024 | $6.78M | Mar 25, 2026 |
| FY2024 | Dec 31, 2023 | $6.92M | Apr 15, 2025 |
| FY2022 | Dec 31, 2022 | $7.53M | Mar 31, 2023 |
| FY2022 | Dec 31, 2021 | $6.48M | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $16.00M | Mar 28, 2022 |
| FY2021 | Dec 31, 2019 | $6.88M | Mar 28, 2022 |
| FY2020 | Dec 31, 2018 | $2.43M | Mar 23, 2021 |
| FY2019 | Dec 31, 2017 | $5.27M | Mar 24, 2020 |
| FY2018 | Dec 31, 2016 | $9.12M | Mar 22, 2019 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2018 | Dec 31, 2018 | $495.6K | Mar 22, 2019 |
| FY2018 | Dec 31, 2017 | $281.6K | Mar 22, 2019 |
| FY2017 | Dec 31, 2016 | $511.1K | Mar 21, 2018 |
| FY2016 | Dec 31, 2015 | $1.33M | Mar 30, 2017 |
| FY2015 | Dec 31, 2014 | $3.51M | Mar 15, 2016 |
| FY2014 | Dec 31, 2013 | $3.66M | Mar 16, 2015 |
| FY2013 | Dec 31, 2012 | $6.02M | Mar 31, 2014 |
| FY2012 | Dec 31, 2011 | $7.72M | Apr 1, 2013 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2022 | Dec 31, 2022 | (2) | Mar 31, 2023 |
| FY2022 | Dec 31, 2021 | 0 | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | 1 | Mar 28, 2022 |
| FY2020 | Dec 31, 2019 | 0 | Mar 23, 2021 |
| FY2019 | Dec 31, 2018 | 0 | Mar 24, 2020 |
| FY2018 | Dec 31, 2017 | 0 | Mar 22, 2019 |
| FY2017 | Dec 31, 2016 | 0 | Mar 21, 2018 |
| FY2015 | Dec 31, 2015 | 0 | Mar 15, 2016 |
| FY2015 | Sep 30, 2015 | 0 | Mar 15, 2016 |
| FY2015 | Jun 30, 2015 | 0 | Mar 15, 2016 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Mar 25, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Mar 25, 2026 |
| FY2024 | Dec 31, 2023 | 0 | Apr 15, 2025 |
| FY2023 | Dec 31, 2022 | (2) | Mar 26, 2024 |
| FY2022 | Dec 31, 2021 | 0 | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | 1 | Mar 28, 2022 |
| FY2020 | Dec 31, 2019 | 0 | Mar 23, 2021 |
| FY2019 | Dec 31, 2018 | 0 | Mar 24, 2020 |
| FY2018 | Dec 31, 2017 | 0 | Mar 22, 2019 |
| FY2017 | Dec 31, 2016 | 0 | Mar 21, 2018 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 9.89M | Mar 25, 2026 |
| FY2025 | Dec 31, 2024 | 9.49M | Mar 25, 2026 |
| FY2024 | Dec 31, 2023 | 8.89M | Apr 15, 2025 |
| FY2023 | Dec 31, 2022 | 8.73M | Mar 26, 2024 |
| FY2022 | Dec 31, 2021 | 8.84M | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | 8.88M | Mar 28, 2022 |
| FY2020 | Dec 31, 2019 | 8.39M | Mar 23, 2021 |
| FY2019 | Dec 31, 2018 | 84.11M | Mar 24, 2020 |
| FY2018 | Dec 31, 2017 | 83.03M | Mar 22, 2019 |
| FY2017 | Dec 31, 2016 | 82.73M | Mar 21, 2018 |